調査レポートカテゴリー： MarketsandMarkets, 世界, 医療/バイオ

In Vitro Lung Model Market by Type (2D, 3D (In-house, Commercial)), Application (Drug Screening, Toxicology, 3D Model Development, Basic Research, Physiologic Research, Stem Cell Research, Regenerative Medicine) - Global Forecasts to 2023

試験管内肺モデルの世界市場予測（～2023年）

◆タイトル：In Vitro Lung Model Market by Type (2D, 3D (In-house, Commercial)), Application (Drug Screening, Toxicology, 3D Model Development, Basic Research, Physiologic Research, Stem Cell Research, Regenerative Medicine) - Global Forecasts to 2023
◆商品コード：BT6203
◆調査・発行会社：MarketsandMarkets
◆発行日：2018年4月25日
◆ページ数：100
◆レポート形式：PDF / 英語
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：医療・バイオ
◆販売価格オプション（消費税別）
Single User（1名利用）USD5,650 ⇒換算￥649,750見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算￥764,750見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算￥937,250見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※商品の納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。（振込先：三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。（但し、対応範囲は弊社で判断）
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

 【レポートの概要】

MarketsandMarketsが発行した当調査レポートでは、試験管内肺モデルの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、種類（2D、3D）別分析、用途別分析、地域別分析、試験管内肺モデルの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

The lung in vitro models market is projected to reach USD 427.4 Million by 2023 from USD 190.5 Million in 2018, at a CAGR of 17.5%. The key factors driving the growth of this market include growing focus on developing alternatives for animal testing models, advancements in cell culture technologies, and the development of new 3D in vitro models.
The report analyzes the lung in vitro models market by type, applications, and region. Based on type, the in vitro lung model market is segmented into 2D cell models and 3D cell models. 3D cell models is further segmented into in-house and commercialized 3D models (ready-to-use). The 3D cell models segment is projected to grow at the fastest rate during the forecast period due to the rising need for efficient lung in vitro models that mimic in vivo physiology.

Based on application, the market is segmented into applications of 2D models and 3D models. Applications of 2D models include drug discovery and toxicology, 3D model development, and basic research. The drug discovery and toxicology segment is expected to hold the largest share of 2D applications in 2018. The drug discovery and toxicology applications dominated the 2D application segment owing to the flexibility and high throughput capabilities of 2D cell models. Applications of 3D models include drug discovery and toxicology, physiological research, and stem cell research & regenerative medicine. The drug discovery and toxicology segment applications of 3D lung in vitro models are expected to dominate the market in 2018. The 3D cell models provide the relevant in vivo environment and reproducibility for drug discovery and toxicology applications.

In Vitro Lung Model Market

Based on region, the in vitro lung model market is segmented into North America, Europe, Asia Pacific, and the RoW. In 2018, North America is projected to account for the largest share of the global lung in vitro models market. The development in the market in North America is driven by the flourishing research environment and abundant funding program such as increased funds for the National Institutes of Health (NIH) and increased R&D activities by biotechnology and pharmaceutical companies.

However, the dearth of skilled professionals such as researchers and technicians that are required to set up and run experiments involving complex in vitro models, is likely to be a challenge for market growth.

The major players in the lung in vitro models market include Epithelix (Switzerland), MatTek Corporation (US), Lonza (Switzerland), ATCC (US), InSphero (Switzerland), Emulate (US), AlveoliX (Switzerland), Oncotheis (Switzerland), Insphero (Switzerland), TissUse (Switzerland), Mimetas (Netherlands), and CN Bio Innovations (UK).

【レポートの目次】

1 Introduction
1.1 Market Definition
1.2 Currency
1.3 Limitations
1.4 Assumptions for the Study
1.5 Years Considered for the Study
1.6 Segmentation

2 Research Methodology
2.1 Research Design
2.2 Primary Research
2.3 Bottom Up Approach
2.4 Top Down Approach
2.5 Market Breakdown

3 Executive Summary

4 Market Dynamic
4.1 Market Overview
4.2 Drivers
4.2.1 Growing Focus on Developing Alternatives for Animal Testing Models
4.2.2 Technological Advancements and the Development of New 3D In Vitro Models
4.2.3 Significant Increase in Research Funding and Venture Capital Investments
4.3 Opportunities
4.3.1 Increasing Number of Drug Discovery Activities
4.3.2 Applications in Regenerative Medicine, Tissue Engineering, and Oncology Research
4.4 Challenges
4.4.1 Dearth of Skilled Professionals

5 In Vitro Lung Model Market, By Type
5.1 Introduction
5.2 2D Cell Models
5.3 3D Cell Models
5.3.1 Commercial 3D Cell Models
5.3.2 Inhouse 3D Cell Models

6 In Vitro Lung Model Market, By Application
6.1 Introduction
6.2 Applications of 2D Models
6.3 Applications of 3D Models

7 In Vitro Lung Model Market, By Region
7.1 Introduction
7.2 North America
7.3 Europe
7.4 APAC
7.5 RoW

8 Competitive Landscape
8.1 Market Overview
8.2 Market Evolution Framework
8.3 Market Ranking Analysis
8.4 Competetive Situations and Trends
8.4.1 Agreements, Partnerships, and Collaborations
8.4.2 Product Launches and Upgrades
8.4.3 Expansions

9 Company Profiles
9.1 Atcc
9.2 Lonza
9.3 Epithelix
9.4 Mattek
9.5 Emulate
9.6 Tissuse
9.7 Mimetas
9.8 Insphero
9.9 Cn Bio Innovations

List of Tables (42 Tables)

Table 1 Lung In Vitro Models Market, By Type, 2016–2023 (USD Million)
Table 2 Lung In Vitro Models Market, By Region, 2016–2023 (USD Million)
Table 3 2D Lung In Vitro Models Market, By Region, 2016–2023 (USD Million)
Table 4 3D Lung In Vitro Models Market, By Type, 2016–2023 (USD Million)
Table 5 3D Lung In Vitro Models Market, By Region, 2016–2023 (USD Million)
Table 6 Commercialized 3D Lung In Vitro Models Market, By Application, 2016–2023 (USD Million)
Table 7 Commercialized 3D Lung In Vitro Models Market, By Region, 2016–2023 (USD Million)
Table 8 In-House 3D Lung In Vitro Models Market, By Application, 2016–2023 (USD Million)
Table 9 In-House 3D Lung In Vitro Models Market, By Region, 2016–2023 (USD Million)
Table 10 2D Lung In Vitro Models Market, By Application, 2016–2023 (USD Million)
Table 11 Drug Discovery & Toxicology Market, By Region, 2016–2023 (USD Million)
Table 12 3D Model Development Market, By Region, 2016–2023 (USD Million)
Table 13 Basic Research Market, By Region, 2016–2023 (USD Million)
Table 14 3D Lung In Vitro Models Market, By Application, 2016–2023 (USD Million)
Table 15 Drug Discovery & Toxicology Market, By Region, 2016–2023 (USD Million)
Table 16 Physiological Research Market, By Region, 2016–2023 (USD Million)
Table 17 Stem Cell & Regenerative Medicine Market, By Region, 2016–2023 (USD Million)
Table 18 Lung In Vitro Models Market, By Country/Region, 2016–2023 (USD Million)
Table 19 North America: Lung In Vitro Models Market, By Type, 2016–2023 (USD Million)
Table 20 North America: 2D Lung In Vitro Models Market, By Application, 2016–2023 (USD Million)
Table 21 North America: 3D Lung In Vitro Models Market, By Type, 2016–2023 (USD Million)
Table 22 North America: Commercialized 3D Lung In Vitro Models Market, By Application, 2016–2023 (USD Million)
Table 23 North America: In-House 3D Lung In Vitro Models Market, By Application, 2016–2023 (USD Million)
Table 24 North America: 3D Lung In Vitro Models Market, By Application, 2016–2023 (USD Million)
Table 25 Europe: Lung In Vitro Models Market, By Type, 2016–2023 (USD Million)
Table 26 Europe: 2D Lung In Vitro Models Market, By Application, 2016–2023 (USD Million)
Table 27 Europe: 3D Lung In Vitro Models Market, By Application, 2016–2023 (USD Million)
Table 28 Europe: Commercialized 3D Lung In Vitro Models Market, By Application, 2016–2023 (USD Million)
Table 29 Europe: In-House 3D Lung In Vitro Models Market, By Application, 2016–2023 (USD Million)
Table 30 Europe:3D Lung In Vitro Models Market, By Application, 2016–2023 (USD Million)
Table 31 Asia Pacific: Lung In Vitro Models Market, By Type, 2016–2023 (USD Million)
Table 32 Asia Pacific: 2D Lung In Vitro Models Market, By Application, 2016–2023 (USD Million)
Table 33 Asia Pacific: 3D Lung In Vitro Models Market, By Type, 2016–2023 (USD Million)
Table 34 Asia Pacific: Commercialized 3D Lung In Vitro Models Market, By Application, 2016–2023 (USD Million)
Table 35 Asia Pacific: In-House 3D Lung In Vitro Models Market, By Application, 2016–2023 (USD Million)
Table 36 Asia Pacific: 3D Lung In Vitro Models Market, By Application, 2016–2023 (USD Million)
Table 37 RoW: Lung In Vitro Models Market, By Type, 2016–2023 (USD Million)
Table 38 RoW: 2D Lung In Vitro Models Market, By Application, 2016–2023 (USD Million)
Table 39 RoW: 3D Lung In Vitro Models Market, By Type, 2016–2023 (USD Million)
Table 40 RoW: Commercialized 3D Lung In Vitro Models Market, By Application, 2016–2023 (USD Million)
Table 41 RoW: In-House 3D Lung In Vitro Models Market, By Application, 2016–2023 (USD Million)
Table 42 RoW: 3D Lung In Vitro Models Market, By Application, 2016–2023 (USD Million)



【レポートのキーワード】

試験管内肺モデル

★調査レポート[試験管内肺モデルの世界市場予測（～2023年）] ( In Vitro Lung Model Market by Type (2D, 3D (In-house, Commercial)), Application (Drug Screening, Toxicology, 3D Model Development, Basic Research, Physiologic Research, Stem Cell Research, Regenerative Medicine) - Global Forecasts to 2023 / BT6203) 販売に関する免責事項
[試験管内肺モデルの世界市場予測（～2023年）] ( In Vitro Lung Model Market by Type (2D, 3D (In-house, Commercial)), Application (Drug Screening, Toxicology, 3D Model Development, Basic Research, Physiologic Research, Stem Cell Research, Regenerative Medicine) - Global Forecasts to 2023 / BT6203) についてEメールでお問い合わせ

※関連データはありません。


◆H&Iグローバルリサーチ株式会社のお客様（例）◆